Zoetis Inc.
A maker of medicines, vaccines, and diagnostics for animals, Zoetis sells well-known products like the dog itch-relief drugs Apoquel and Cytopoint and Simparica parasite preventives to veterinarians worldwide. Born in the 1950s as the animal health arm of Pfizer, it became a fully independent company in 2013. Its name comes from the Greek word "zoe," meaning life—a fitting nod to its mission of keeping animals healthy.
Bought 3.0K
Bought 2.0K
Bought 6.7K
Granted 12.1K
Granted 1.5K
Granted 1.6K
Granted 259
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| McCallister Michael BDirector · 2 transactions | — | 39.3K | — | 3.0K | — |
| Bisaro PaulDirector · 1 transaction | +7.7% | 27.9K | — | 2.0K | — |
| Damelio Frank ADirector · 1 transaction | +44.9% | 21.5K | — | 6.7K | — |
| Parent Louise MDirector · 2 transactions | +7.9% | 18.2K | 12.1K | — | — |
| Norden GregoryDirector · 1 transaction | 0% | 18.2K | — | — | — |
| Sarbaugh KeithExecutive Vice President · 2 transactions | +42.9% | 3.3K | 1.5K | — | — |
| Stetter MarkDirector · 1 transaction | — | 1.6K | 1.6K | — | — |
| Esch KevinExecutive Vice President · 2 transactions | +20.5% | 1.1K | 259 | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: +11.7K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.